Related Experiment Video
Updated: Jun 21, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Pre-screening HIV-1 reverse transcriptase resistance mutations in subtype B patients using a novel multiplex primer
Martin Roelsgaard Jakobsen1, Anni Aggerholm, Louise Bruun Jørgensen
1Department of Infectious Diseases, Aarhus University Hospital, Skejby, Brendstrupgaardvej 100, DK-8200 Aarhus N, Denmark. mrj@svf.au.dk
Current HIV Research
|July 16, 2009
Summary
A new HIV drug resistance test, HIV-SNaPshot, detects mutations in HIV-1 reverse transcriptase inhibitors at low levels. This sensitive method aids in pre-treatment resistance screening for better antiretroviral therapy outcomes.
Area of Science:
- Molecular Biology
- Virology
- Genetics
Background:
- Antiretroviral therapy (ART) is crucial for managing HIV, but drug resistance can limit treatment efficacy.
- Rising transmitted drug resistance necessitates effective pre-treatment screening methods.
- Detecting minority drug resistance mutations is vital for optimizing ART regimens.
Purpose of the Study:
- To develop and evaluate a sensitive multiplex assay for detecting HIV-1 drug resistance mutations.
- To assess the utility of the HIV-SNaPshot assay in identifying resistance to reverse transcriptase inhibitors.
- To compare the performance of HIV-SNaPshot with existing genotyping systems.
Main Methods:
- Development of a multiplex primer extension assay (HIV-SNaPshot).
- Utilized capillary electrophoresis for reporting nucleotide alterations at nine key drug resistance positions.
- Tested assay sensitivity down to 5% in viral quasispecies populations.
Main Results:
- HIV-SNaPshot successfully detected drug resistance mutations in HIV-1 subtype B and most non-B subtypes.
- The assay demonstrated sensitivity in detecting mutations present at 5% levels.
- Comparison with the Viroseq system showed similar results, with HIV-SNaPshot identifying additional mutations in several patients.
Conclusions:
- HIV-SNaPshot is a sensitive multiplex method for detecting HIV-1 drug resistance mutations.
- The assay supports standard genotyping by identifying minority resistance mutations.
- HIV-SNaPshot offers equivalent or greater sensitivity compared to the Viroseq system for resistance screening.
